Red Flags Detected

  • Departure Of Cfo (new) — The CFO departed effective April 15, 2026, as determined by the Board with no disclosed reason.
NASDAQ: TNGX Tango Therapeutics, Inc. 8-K

Tango Therapeutics CFO Daniella Beckman departs with generous severance package

Filed May 8, 2026 · Period ending May 7, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TNGX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · Jun 5, 2026 4:33 PM